X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DR. DATSONS LABS - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DR. DATSONS LABS PFIZER/
DR. DATSONS LABS
 
P/E (TTM) x 30.5 -10.9 - View Chart
P/BV x 5.2 0.2 3,192.7% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 PFIZER   DR. DATSONS LABS
EQUITY SHARE DATA
    PFIZER
Mar-16
DR. DATSONS LABS
Mar-14
PFIZER/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs2,724126 2,168.8%   
Low Rs1,61131 5,213.6%   
Sales per share (Unadj.) Rs440.9133.0 331.5%  
Earnings per share (Unadj.) Rs48.70.2 32,118.0%  
Cash flow per share (Unadj.) Rs75.86.6 1,146.7%  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs462.9128.8 359.5%  
Shares outstanding (eoy) m45.7531.66 144.5%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x4.90.6 835.6%   
Avg P/E ratio x44.5516.1 8.6%  
P/CF ratio (eoy) x28.611.8 241.6%  
Price / Book Value ratio x4.70.6 770.6%  
Dividend payout %30.80-   
Avg Mkt Cap Rs m99,1632,477 4,002.7%   
No. of employees `0002.9NA-   
Total wages/salary Rs m2,75856 4,924.1%   
Avg. sales/employee Rs Th6,981.7NM-  
Avg. wages/employee Rs Th954.5NM-  
Avg. net profit/employee Rs Th771.1NM-  
INCOME DATA
Net Sales Rs m20,1704,211 479.0%  
Other income Rs m85779 1,089.5%   
Total revenues Rs m21,0284,289 490.2%   
Gross profit Rs m4,310569 758.0%  
Depreciation Rs m1,239204 606.0%   
Interest Rs m5430 1.2%   
Profit before tax Rs m3,92313 30,892.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,7946 29,416.4%   
Profit after tax Rs m2,2285 46,411.9%  
Gross profit margin %21.413.5 158.2%  
Effective tax rate %45.748.0 95.2%   
Net profit margin %11.00.1 9,688.4%  
BALANCE SHEET DATA
Current assets Rs m16,2996,852 237.9%   
Current liabilities Rs m7,5946,711 113.2%   
Net working cap to sales %43.23.3 1,288.7%  
Current ratio x2.11.0 210.2%  
Inventory Days Days65161 40.6%  
Debtors Days Days26318 8.1%  
Net fixed assets Rs m8,6223,673 234.7%   
Share capital Rs m458317 144.5%   
"Free" reserves Rs m20,7223,761 551.0%   
Net worth Rs m21,1804,078 519.4%   
Long term debt Rs m251,671 1.5%   
Total assets Rs m29,13712,633 230.7%  
Interest coverage x755.51.0 73,381.8%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.70.3 207.7%   
Return on assets %7.73.4 222.6%  
Return on equity %10.50.1 8,935.1%  
Return on capital %19.07.7 247.5%  
Exports to sales %0.122.9 0.3%   
Imports to sales %17.514.3 122.3%   
Exports (fob) Rs m12964 1.2%   
Imports (cif) Rs m3,526602 585.8%   
Fx inflow Rs m52964 5.4%   
Fx outflow Rs m140607 23.1%   
Net fx Rs m-88357 -24.7%   
CASH FLOW
From Operations Rs m3,4361,345 255.5%  
From Investments Rs m-6,991-2,256 309.9%  
From Financial Activity Rs m-619-1,200 51.6%  
Net Cashflow Rs m-4,174-2,111 197.7%  

Share Holding

Indian Promoters % 0.0 4.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 4.9 1.4 363.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 94.1 25.2%  
Shareholders   85,207 20,807 409.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES SHASUN LTD  

Compare PFIZER With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


May 25, 2018 03:35 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS